Association between mixed oil lipid emulsions and all‐cause infections relative to soybean oil lipid emulsions in hospitalized adults: A retrospective cohort study
- 7 September 2025
- journal article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 50 (1) , 78-87
Abstract
Background: Intravenous lipid emulsions are a key component of parenteral nutrition, and their fatty acid compositions may influence immune responses and clinical outcomes. Methods: This retrospective cohort study conducted from January 2020 to December 2022 compared clinical outcomes of hospitalized non–critical care patients receiving parenteral nutrition with either mixed oil or soybean oil lipid emulsions for at least 48 h. The primary outcome was a composite of the presence of pneumonia, urinary tract infection, or an intra‐abdominal collection diagnosed within 14 days of initiating parenteral nutrition. Secondary outcomes included catheter‐related bloodstream infection, length of hospital stay, duration of antibiotic therapy, in‐hospital mortality, and changes in the aspartate transaminase (AST)/alanine transaminase (ALT) ratio over time. Results: Among 266 patients (mixed oil lipid emulsion: n = 130; soybean oil lipid emulsion: n = 136) there was no statistically significant difference in all‐cause infections ( P = 0.21). In patients receiving lipid emulsions for >7 days, the use of mixed oil lipid emulsions was associated with a shorter median antibiotic duration (4 days: interquartile range [IQR] 1–8.5 vs 7 days: IQR 5–10; P = 0.04). Additionally, patients who received mixed oil emulsions for >7 days had a significantly greater change in the AST/alkaline phosphatase ratio after 14 days compared with the soybean oil group (β = –0.51; P = 0.02). Conclusion: Although there was no difference in all‐cause infections between types of lipid emulsions, mixed oil lipid emulsions were associated with shorter antibiotic use and lower AST/ALT ratio in hospitalized, non–critical care patients receiving parenteral nutrition for >7 days.Keywords
This publication has 31 references indexed in Scilit:
- Immunomodulatory Effects of Omega‐3 Fatty Acids: Mechanistic Insights and Health ImplicationsMolecular Nutrition & Food Research, 2025
- Early predictors of liver injury in patients on parenteral nutritionClinical Nutrition ESPEN, 2022
- Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral NutritionJournal of Parenteral and Enteral Nutrition, 2021
- Evaluation of Fibrosis in Intestinal Failure–Associated Liver Disease in the Sustain RegistryJournal of Parenteral and Enteral Nutrition, 2020
- An Observational Study of Smoflipid vs Intralipid on the Evolution of Intestinal Failure–Associated Liver Disease in Infants With Intestinal FailureJournal of Parenteral and Enteral Nutrition, 2019
- ω‐3 Fatty‐Acid Enriched Parenteral Nutrition in Hospitalized Patients: Systematic Review With Meta‐Analysis and Trial Sequential AnalysisJournal of Parenteral and Enteral Nutrition, 2019
- Parenteral fish oil and liver function tests in hospitalized adult patients receiving parenteral nutrition: A propensity score-matched analysisClinical Nutrition, 2017
- Management of acute intestinal failure: A position paper from the European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest GroupClinical Nutrition, 2016
- Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid) – A double-blind, randomised, multicentre study in adultsClinical Nutrition, 2013
- Validity and Clinical Utility of the Aspartate Aminotransferase–Alanine Aminotransferase Ratio in Assessing Disease Severity and Prognosis in Patients With Hepatitis C Virus–Related Chronic Liver DiseaseArchives of internal medicine (1960), 2003